Immune checkpoint inhibitors are effective only when CD8+ T cells infiltrate the tumor; thus, immune checkpoint inhibitors alone are ineffective against PCa because CD8+ T cells do not infiltrate the tumor [74,75]. The gene discussed is CD8A; the disease is posterior cortical atrophy.